$0.28 0.00 (0%)
10/12/2011 3:53 PM

Labopharm, Inc. (NASDAQOTH:DDSSF.DL)

CAPS Rating: No stars

An international, specialty pharmaceutical company focused on improving existing drugs by incorporating its proprietary, advanced controlled-release technologies.

Recs

1
Player Avatar msamet1 (87.62) Submitted: 3/30/2007 10:40:23 AM : Underperform Start Price: $5.72 DDSSF.DL Score: +79.90

Drug delivery and reformulation is a crowded sector and requires branded life cycle extensions for strategies to be profitable

Report this Post 4 Comments
Member Avatar dhaddad (< 20) Submitted: 6/1/2007 3:17:32 PM
Recs: 0

Great call! It's got to be a nice feeling when you're the only one in the entire CAPS universe that picks an underperformer (supported with a pitch). Kudos to you...hope you had it shorted in real life!

Member Avatar tazeat (89.17) Submitted: 6/1/2007 6:43:41 PM
Recs: 0

Nice timing :).

Member Avatar msamet1 (87.62) Submitted: 1/7/2008 4:47:14 PM
Recs: 0

thanks for the kind comments but my "pitch" comes from being a VC on the left coast and watching various life science sectors. I've avoided loosing a LOT because of street level experiences in the trenches.Can't learn what I've learned in ANY MBA program.

Member Avatar zzlangerhans (99.24) Submitted: 9/26/2008 3:18:59 PM
Recs: 0

Can't argue with the call but I can't understand your pitch. I doubt any of those other guys did either.

Featured Broker Partners


Advertisement